Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Colgate-Palmolive Company sees impressive growth under institutional shareholders control

January 07, 2025
Colgate-Palmolive Company (NYSE:CL) investors have enjoyed a substantial 46% return over the past five years, according to Yahoo Finance. This growth can largely be attributed to the company's institutional shareholders, who own a significant 85% stake in the company, as reported by Simply Wall St News. With such control, these investors have steered the company towards success.

Institutional shareholders play a crucial role in the company's decision-making, offering stability and long-term growth prospects. They provide expertise, capital, and strategic guidance to ensure the company's continued success. This level of institutional ownership demonstrates a high level of confidence in Colgate-Palmolive's potential.

Investors looking for a reliable dividend stock might find Colgate-Palmolive Company to be an excellent choice. Insider Monkey suggests that it could be the best January dividend stock to buy. By investing in Colgate-Palmolive, investors can gain exposure to a company with a strong track record and a commitment to rewarding shareholders.

To make informed investment decisions, it is always recommended to consult professionals in the field. Stocks Prognosis offers expert advice and forecasts on the movement of Colgate-Palmolive's stock. Their insights can help investors make wise choices and maximize potential returns.

In conclusion, Colgate-Palmolive Company's growth under the control of institutional shareholders is worth noting. With a solid track record, institutional support, and the potential for dividend returns, investors may want to consider buying the stock. For a more accurate prediction of the stock's movement, consulting professionals like Stocks Prognosis is highly recommended.
If you want to leave a comment, then you need Login or Register





Other data for CL

Related data

CLAugust 18, 2025Colgate-Palmolive's CL Share Buybacks and Modest Guidance: What Do They Reveal About Capital Allocation  ~1 min.

Colgate-Palmolive Company recently announced its plans for share buybacks and provided modest guidance for the future....


CLAugust 4, 2025QuantWave Achieves 9.77% Profit Target Forecast for Colgate-Palmolive Company  ~1 min.

On May 30, 2025, QuantWave, an automated forecasting platform, successfully predicted a short direction for the stock of Colgate-Palmolive Company with a price target of 83.36 $....


CLAugust 4, 2025COLGATE-PALMOLIVE COMPANY Hits Price Target Forecast with 10.54% Profit  ~1 min.

On April 15, 2025, QuantWave, a leading automated forecasting platform, issued a short signal for COLGATE-PALMOLIVE COMPANY with a price target forecast of 83.36 USD. The stock was trading at 93....


CLAugust 4, 2025QuantWave Successfully Predicts Colgate-Palmolive Stock Price Movement, Profiting 8.78%  ~1 min.

QuantWave, the leading automated forecasting platform, has once again delivered on its promise of accurate stock price predictions....


CLAugust 4, 2025QuantWave Hits Bulls-eye with Colgate-Palmolive Stock Forecast, Yielding 7.46% Profit  ~2 min.

On June 3, 2025, QuantWave, the innovative automated forecasting platform, issued a short signal for Colgate-Palmolive Company's stock, which was trading at $90.08....


CLAugust 1, 2025QuantWave Hits the Mark with Colgate-Palmolive Company Price Target Forecast, Delivering 7.36% Profit  ~1 min.

Colgate-Palmolive Company (CL) investors are celebrating as QuantWave's price target forecast for the stock has been successfully achieved, resulting in a significant profit of 7.36%....


CLAugust 1, 2025QuantWave Achieves 9.01% Profit Target for Colgate-Palmolive Company Stock  ~1 min.

QuantWave, the automated forecasting platform, successfully hit its price target for Colgate-Palmolive Company stock. The forecast signal was issued on April 29, 2025, with a price of $91....


CLAugust 1, 2025QuantWave Successfully Forecasts Colgate-Palmolive Company Stock, Generating Profit of 10.54%  ~1 min.

On April 25, 2025, QuantWave's automated forecasting platform issued a signal for Colgate-Palmolive Company stock, predicting a short direction with a price of $93.35....


CLAugust 1, 2025QuantWave Achieves 7.64% Profit Target Forecast for Colgate-Palmolive Company  ~2 min.

On April 28, 2025, QuantWave, the automated forecasting platform, released a short signal for Colgate-Palmolive Company (CL) with a price target of $83.51. The stock was trading at $90....


CLAugust 1, 2025COLGATE-PALMOLIVE COMPANY Stock Hits Price Target Forecast with 8.87% Profit  ~1 min.

QuantWave's forecast for COLGATE-PALMOLIVE COMPANY stock has proven to be accurate, with the predicted short direction reaching its target on August 1, 2025....


MOFebruary 27, 2025Analysts Recommend Investing in Altria Group Inc. as Institutional Investors Hold 61% Ownership  ~2 min.

With a substantial 61% ownership in Altria Group Inc. (NYSE:MO) by institutional investors, the company holds a significant level of trust and confidence from the market....


ABBVJanuary 9, 2025AbbVie Inc. NYSE:ABBV Captivates Institutional Shareholders with 73% Ownership  ~2 min.

AbbVie Inc., the renowned pharmaceutical company listed on NYSE under the ticker symbol ABBV, boasts an impressive 73% ownership by institutional shareholders....


INFYJanuary 10, 2025Infosys Limited: Largely Controlled by Institutional Shareholders  ~1 min.

Infosys Limited (NYSE: INFY) has recently come into the spotlight as it is revealed that the company is largely controlled by institutional shareholders, who own 56% of the company....


FCXNovember 28, 2024Freeport-McMoRan Inc. Attracts Institutional Investors with an Impressive 85% Ownership - Stocks Prognosis  ~1 min.

Freeport-McMoRan Inc. (NYSE:FCX) continues to catch the attention of institutional owners who now hold a remarkable 85% ownership of the company, according to Yahoo Finance....


ABBVDecember 4, 2024ABBVIE INC.: A Leading Pharmaceutical Company with High Institutional Ownership  ~2 min.

AbbVie Inc. (NYSE: ABBV) is gaining attention in the investment world due to its high institutional ownership....